Overview

This test aims to verify that the management process of renal anemia in maintenance hemodialysis patients can improve the hemoglobin compliance rate better than that of anemia management by primary doctors, and promote the system at the grassroots level to guide primary doctors in anemia management and improve the management standard of renal anemia in maintenance hemodialysis patients through prospective randomized controlled trials. To improve the anemia compliance rate of maintenance hemodialysis patients, and to improve the basic doctors' grasp of the anemia management guidelines, consensus and standard operating procedures.

Eligibility

Inclusion Criteria:

        ① Age over 18 years old; ② Receive regular hemodialysis at least twice a week for at least
        3 months, and have no plans to stop hemodialysis within 6 months since the start of the
        trial; ③ The patient voluntarily participated in this study.
        Exclusion Criteria:
          -  Patients who have planned to undergo kidney transplantation or terminate hemodialysis
             during the study period; ② Previous history of bone marrow hematopoietic system
             diseases, such as combined myelodysplastic syndrome, multiple myeloma, and other
             diseases; ③ Any known hereditary blood disease, such as thalassemia, sickle cell
             anemia, pure red blood cell aplasia, etc.; ④ Active or chronic gastrointestinal
             bleeding; ⑤ There was a severe infection within one week prior to screening.